🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Start Date
2019-06-26
Trial ID
NCT03998254
A phase I/II trial conducted in a single centre, observer-blind, randomized...
Status
Completed
Location
Miami Research Associates
Start Date
2013-10-08
Trial ID
NCT01991587
This study was conducted in 2 parts. Part A was a randomized, double-blind,...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT00365716
The purpose of this study is to determine the safety of and immune response...
Status
Completed
Location
Usc La Nichd Crs
Start Date
2006-10
Trial ID
NCT00339040
The primary purpose of the study is to determine if an investigational vacc...
Status
Completed
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00092495
Treatments Being Tested
In 2013, the Investigators enrolled a cohort of 180 HIV-1 infected adolesce...
Status
Unknown
Location
Multiple Locations
Start Date
2021-08
Trial ID
NCT04920526
Treatments Being Tested
Primary objective: • To demonstrate that administration of V503 induces no...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-23
Trial ID
NCT01304498
This is a study of V501 \[quadrivalent Human Papillomavirus (HPV) (Type 6, ...
Status
Completed
Location
MSD K.K.
Start Date
2015-11-20
Trial ID
NCT02576054
Treatments Being Tested
The primary purpose of the study is to test the safety of HPV Vaccine in Wo...
Status
Completed
Location
Multiple Locations
Start Date
2001-12-28
Trial ID
NCT00517309
This is a multiple sites phase II trial, randomized, observer-blind, dose r...
Status
Completed
Location
MUHC-Vaccine Study Centre
Start Date
2014-07-16
Trial ID
NCT02236052